Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial

Abstract Background HIV-infected individuals on antiretroviral therapy (ART) require treatment with artemisinin-based combination therapy (ACT) when infected with malaria. Dihydroartemisinin–piperaquine (DPQ) is recommended for treatment of Plasmodium falciparum malaria, but its efficacy and safety...

Full description

Bibliographic Details

Published in:	Malaria Journal
Main Authors:	Esperança Sevene, Clifford G. Banda, Mavuto Mukaka, Sonia Maculuve, Salésio Macuacua, Anifa Vala, Mireia Piqueras, Linda Kalilani-Phiri, Jane Mallewa, Dianne J. Terlouw, Saye H. Khoo, David G. Lalloo, Victor Mwapasa
Format:	Article
Language:	English
Published:	BMC 2019-08-01
Subjects:	Human immunodeficiency virus Antiretroviral drugs Dihydroartemisinin–piperaquine Malaria Drug–drug interactions
Online Access:	http://link.springer.com/article/10.1186/s12936-019-2909-5